A cacao plant edited to resist one of the world's most damaging crop diseases is now being evaluated in field collaborations with the U.S. Department of Agriculture in Hawaii and Puerto Rico, and Penn State has licensed it to a company planning to scale it up. The university announced the next steps on Oct. 27, according to a Penn State release.

The plant carries a tiny change to a gene called TcNPR3, which acts as a brake on the plant's immune system. In laboratory tests, edited seedlings developed about 42% less black pod disease, a fungus-like infection that causes roughly 30% of cacao yield losses worldwide. The original study was published in 2025, so the new development is the move toward real-world testing and commercialization, not the discovery itself.

The work lands as chocolate lovers head into Halloween after two turbulent years for cocoa. Supply problems in West Africa, which grows most of the world's cacao, sent prices to record highs in 2024, and disease is one of the threats farmers say they cannot easily control.

Two DNA Letters Out of 450 Million

The team, led by Mark Guiltinan, professor of plant molecular biology, and Siela Maximova, research professor of plant biotechnology, used CRISPR to alter TcNPR3. Loosening that brake partially switches on the plant's defenses against Phytophthora, the pathogen behind black pod. In one case, Guiltinan said, "we only changed two bases in the entire genome of the plant," out of roughly 450 million.

The results were published in the Plant Biotechnology Journal. After researchers infected leaves with the pathogen, lesions on edited plants averaged 0.92 square centimeters, compared with 1.5 square centimeters on unedited plants. Seven offspring were confirmed by whole-genome sequencing to carry the edit without any leftover gene-editing machinery, and they grew normally.

The edit worked by dialing down the brake rather than removing it. In plants carrying one edited copy, activity of TcNPR3 fell by about half, while a related defense gene, TcNPR1, was unchanged. About 119 other genes shifted their activity, a sign that the plant's defense network had been nudged into a more alert state without obvious harm to growth.

Gene Editing Versus Conventional GMOs

The distinction matters to shoppers and regulators. Conventional genetically modified crops typically carry DNA inserted from another organism, such as a bacterial gene for insect resistance. This cacao carries no foreign DNA. The CRISPR tools used to make the edit were removed through ordinary breeding, leaving only a small change to the plant's own gene.

Because of that, Penn State says the plant is no longer considered a GMO under U.S. and European Union frameworks that treat certain gene-edited traits like those produced through conventional breeding. Those rules are still evolving, however, and labeling and approval requirements differ by country. Chocolate made from such cacao would still face separate decisions by food companies about whether and how to use it.

The project has industry ties that readers should know about. Penn State's cacao program grew out of an industry-supported endowment established in the 1980s, and the university licensed the new plant to AgroNetica, a cacao-focused biotechnology company that plans field testing, scale-up, and sales. Financial terms were not disclosed.

From Greenhouse to Field

The 42% figure comes from controlled laboratory and greenhouse tests, not farms. The researchers did not measure yield, and cacao trees take years to mature and produce pods, so it is not yet known how the edited plants will perform in rain, heat and mixed infections over a full growing cycle. The study authors said longer field trials are needed to confirm agronomic performance.

Hawaii and Puerto Rico are among the few places under U.S. jurisdiction warm and humid enough to grow cacao, which makes them natural test beds. The release did not name specific trial sites or a timeline for farmer access. Maximova noted that bringing a new crop variety to growers can take many years and millions of dollars, which is why the team sought a commercial partner.

A disease-resistant tree would help only if farmers can obtain it. Most cacao is grown on small family farms in Côte d'Ivoire, Ghana and other tropical countries, where seedling costs, local regulations and buyer acceptance will shape any rollout.

Chocolate Prices Remain Volatile

Cocoa futures topped $12,900 per ton in December 2024, a record, before falling sharply. They traded near $5,600 per ton on Oct. 23, 2026, down from a 2026 high of $6,821 on Aug. 31 but about double the March low, Yahoo Finance reported. Michael Whitehead, director of agribusiness at ANZ, described cacao as "a relatively fragile crop that so much of the world depends on."

Weather is the immediate worry. Heavy rain in Côte d'Ivoire has delayed harvests, while below-average rainfall in parts of West Africa has raised concerns about the crop expected in early 2027, according to Trading Economics. Wet conditions also favor diseases such as black pod — the kind of pressure the edited plant is meant to ease.

For households, the link to store prices is indirect. Chocolate makers buy cocoa months ahead, so wholesale swings reach shelves slowly, and a new tree variety would take years to affect supply. No one should expect gene-edited cacao to lower candy prices this Halloween or next.

The next milestones are results from the USDA field evaluations and AgroNetica's plans for testing and seedling production. The bottom line is that a two-letter DNA edit cut black pod disease by about 42% in early tests — a promising tool for a fragile crop, but one that still has to prove itself on farms before it can steady chocolate supplies.

What Readers Want to Know

What did Penn State researchers do?

They used CRISPR to change two DNA letters in a cacao gene called TcNPR3, which normally restrains the plant's immune system.

How well did it work?

In laboratory tests, edited plants showed about 42% less black pod disease than unedited plants.

Is the edited cacao a GMO?

Penn State says no under U.S. and EU frameworks, because it contains no foreign DNA. Rules differ by country and are still changing.

Where is it being tested?

In field evaluations with the USDA in Hawaii and Puerto Rico. Specific sites were not disclosed.

Will it lower chocolate prices?

Not soon. Field trials, scale-up, and farmer adoption would take years.

What is black pod disease?

It is an infection caused by Phytophthora that rots cacao pods and causes roughly 30% of global yield losses.

Who will bring it to market?

Penn State licensed the plant to AgroNetica, a cacao biotechnology company.